Biolux Technology, an Anières, Switzerland-based advanced light-accelerated orthodontics company, raised $4.5M in funding.
The round was led by redalpine and Revere Partners.
The company intends to use the funds to accelerate the development of OrthoPulse®, advance clinical research, and develop innovative solutions that improve patient outcomes and revolutionize orthodontic treatment worldwide.
Led by CEO Marcel Pordes, Biolux Technology is an innovator in light-accelerated orthodontics, dedicated to developing advanced technologies that improve patient outcomes and treatment experiences. Its flagship product, OrthoPulse®, uses near-infrared light therapy to safely and effectively accelerate tooth movement, reduce treatment time and treatment discomfort. In this way, OrthoPulse improves the predictability of aligner treatments, enhancing the overall orthodontic experience.
It features patented light-accelerated technology and a low failure rate for more reliable treatment. Using safe near-infrared light therapy, OrthoPulse® accelerates tooth movement, cutting treatment times by up to 50%. This game-changing approach not only shortens the orthodontic process but also tackles a critical issue in patient care – longer treatments often lead to reduced compliance and more expensive, time-consuming refinements. With this new funding, Biolux Technology will
FinSMEs
13/11/2024